Biotage AB (publ) (BIOT.ST)
SEK 158.8
(1.73%)
SEK 158.8
(1.73%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.33 SEK | -17.98% |
| 2022 | 4.06 SEK | 29.3% |
| 2021 | 3.14 SEK | 16.73% |
| 2020 | 2.69 SEK | -6.27% |
| 2019 | 2.87 SEK | 10.81% |
| 2018 | 2.59 SEK | 21.03% |
| 2017 | 2.14 SEK | 49.65% |
| 2016 | 1.43 SEK | 26.55% |
| 2015 | 1.13 SEK | 13.0% |
| 2014 | 1.00 SEK | 63.93% |
| 2013 | 0.61 SEK | 17.31% |
| 2012 | 0.52 SEK | 23.81% |
| 2011 | 0.42 SEK | 108.55% |
| 2010 | -4.91 SEK | -3373.33% |
| 2009 | 0.15 SEK | -95.56% |
| 2008 | 3.38 SEK | 201.79% |
| 2007 | 1.12 SEK | 3633.33% |
| 2006 | 0.03 SEK | 105.26% |
| 2005 | -0.57 SEK | 71.36% |
| 2004 | -1.99 SEK | 52.96% |
| 2003 | -4.23 SEK | 12.6% |
| 2002 | -4.84 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.55 SEK | -6.67% |
| 2024 Q2 | 0.60 SEK | 46.34% |
| 2024 Q1 | 0.41 SEK | -75.0% |
| 2023 Q1 | 0.65 SEK | -41.96% |
| 2023 FY | - SEK | -17.98% |
| 2023 Q3 | 0.48 SEK | -2.04% |
| 2023 Q2 | 0.49 SEK | -24.62% |
| 2023 Q4 | 1.64 SEK | 241.67% |
| 2022 Q3 | 0.99 SEK | 15.12% |
| 2022 FY | - SEK | 29.3% |
| 2022 Q1 | 1.08 SEK | 54.29% |
| 2022 Q2 | 0.86 SEK | -20.37% |
| 2022 Q4 | 1.12 SEK | 13.13% |
| 2021 FY | - SEK | 16.73% |
| 2021 Q1 | 0.92 SEK | 35.29% |
| 2021 Q2 | 0.71 SEK | -22.83% |
| 2021 Q4 | 0.70 SEK | -13.58% |
| 2021 Q3 | 0.81 SEK | 14.08% |
| 2020 Q1 | 0.94 SEK | 235.71% |
| 2020 FY | - SEK | -6.27% |
| 2020 Q4 | 0.68 SEK | 19.3% |
| 2020 Q3 | 0.57 SEK | 16.33% |
| 2020 Q2 | 0.49 SEK | -47.87% |
| 2019 FY | - SEK | 10.81% |
| 2019 Q3 | 1.02 SEK | 22.89% |
| 2019 Q2 | 0.83 SEK | 13.7% |
| 2019 Q1 | 0.73 SEK | 73.81% |
| 2019 Q4 | 0.28 SEK | -72.55% |
| 2018 Q1 | 0.69 SEK | 27.78% |
| 2018 FY | - SEK | 21.03% |
| 2018 Q2 | 0.79 SEK | 14.49% |
| 2018 Q3 | 0.68 SEK | -13.92% |
| 2018 Q4 | 0.42 SEK | -38.24% |
| 2017 Q3 | 0.48 SEK | -17.24% |
| 2017 Q1 | 0.55 SEK | 103.7% |
| 2017 Q2 | 0.58 SEK | 5.45% |
| 2017 FY | - SEK | 49.65% |
| 2017 Q4 | 0.54 SEK | 12.5% |
| 2016 Q4 | 0.27 SEK | -37.21% |
| 2016 FY | - SEK | 26.55% |
| 2016 Q2 | 0.38 SEK | 8.57% |
| 2016 Q1 | 0.35 SEK | 9.37% |
| 2016 Q3 | 0.43 SEK | 13.16% |
| 2015 FY | - SEK | 13.0% |
| 2015 Q4 | 0.32 SEK | 14.29% |
| 2015 Q3 | 0.28 SEK | 16.67% |
| 2015 Q2 | 0.24 SEK | -17.24% |
| 2015 Q1 | 0.29 SEK | 11.54% |
| 2014 FY | - SEK | 63.93% |
| 2014 Q2 | 0.24 SEK | 100.0% |
| 2014 Q3 | 0.17 SEK | -29.17% |
| 2014 Q1 | 0.12 SEK | -58.62% |
| 2014 Q4 | 0.26 SEK | 52.94% |
| 2013 Q3 | 0.10 SEK | -47.37% |
| 2013 FY | - SEK | 17.31% |
| 2013 Q1 | 0.04 SEK | -78.95% |
| 2013 Q2 | 0.19 SEK | 375.0% |
| 2013 Q4 | 0.29 SEK | 190.0% |
| 2012 Q4 | 0.19 SEK | 280.0% |
| 2012 Q3 | 0.05 SEK | -72.22% |
| 2012 Q1 | 0.11 SEK | -50.0% |
| 2012 Q2 | 0.18 SEK | 63.64% |
| 2012 FY | - SEK | 23.81% |
| 2011 FY | - SEK | 108.55% |
| 2011 Q2 | 0.03 SEK | 50.0% |
| 2011 Q3 | 0.15 SEK | 400.0% |
| 2011 Q4 | 0.22 SEK | 46.67% |
| 2011 Q1 | 0.02 SEK | 100.38% |
| 2010 Q3 | 0.06 SEK | -25.0% |
| 2010 Q2 | 0.08 SEK | 100.0% |
| 2010 Q1 | 0.04 SEK | -87.5% |
| 2010 FY | - SEK | -3373.33% |
| 2010 Q4 | -5.33 SEK | -8983.33% |
| 2009 Q2 | 0.06 SEK | 125.0% |
| 2009 Q4 | 0.32 SEK | 3100.0% |
| 2009 Q1 | -0.24 SEK | 0.0% |
| 2009 FY | - SEK | -95.56% |
| 2009 Q3 | 0.01 SEK | -83.33% |
| 2008 FY | - SEK | 201.79% |
| 2007 FY | - SEK | 3633.33% |
| 2006 FY | - SEK | 105.26% |
| 2005 FY | - SEK | 71.36% |
| 2004 FY | - SEK | 52.96% |
| 2003 FY | - SEK | 12.6% |
| 2002 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AddLife AB (publ) | 1.56 SEK | -113.462% |
| Bonesupport Holding AB (publ) | 3.77 SEK | 11.671% |
| Doxa AB (publ) | 0.60 SEK | -455.0% |
| Elekta AB (publ) | 3.41 SEK | 2.346% |
| iZafe Group AB (publ) | -0.14 SEK | 2478.571% |
| Ortivus AB (publ) | -0.41 SEK | 912.195% |
| Ortivus AB (publ) | -0.41 SEK | 912.195% |
| Q-linea AB (publ) | -3.48 SEK | 195.69% |
| S2Medical AB (publ) | -0.14 SEK | 2478.571% |
| Synsam AB (publ) | 2.09 SEK | -59.33% |